Tilman Schöning

435 total citations
9 papers, 135 citations indexed

About

Tilman Schöning is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Tilman Schöning has authored 9 papers receiving a total of 135 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pathology and Forensic Medicine and 3 papers in Hematology. Recurrent topics in Tilman Schöning's work include Lymphoma Diagnosis and Treatment (3 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Tilman Schöning is often cited by papers focused on Lymphoma Diagnosis and Treatment (3 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Tilman Schöning collaborates with scholars based in Germany and United Kingdom. Tilman Schöning's co-authors include Annette Altmann, Ralf Jesenofsky, Anthony D. Ho, Vasileios Askoxylakis, Michael Eisenhut, Uwe Haberkorn, Annette Markert, Mathias Witzens‐Harig, Aleksandar Radujkovic and Thomas Luft and has published in prestigious journals such as Blood, Journal of Nuclear Medicine and BMC Cancer.

In The Last Decade

Tilman Schöning

8 papers receiving 132 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tilman Schöning Germany 6 64 37 35 34 23 9 135
Miriam Grazia Ferrara Italy 10 147 2.3× 94 2.5× 23 0.7× 48 1.4× 13 0.6× 18 265
Stefano Di Cecca Italy 10 61 1.0× 65 1.8× 52 1.5× 34 1.0× 74 3.2× 13 226
Dai Keino Japan 7 30 0.5× 38 1.0× 15 0.4× 14 0.4× 17 0.7× 35 117
Alessandro Farris Italy 5 61 1.0× 28 0.8× 16 0.5× 32 0.9× 15 0.7× 6 129
April Shamy Canada 6 43 0.7× 53 1.4× 52 1.5× 18 0.5× 7 0.3× 9 135
Vasiliki Chasapi Greece 7 46 0.7× 41 1.1× 33 0.9× 115 3.4× 13 0.6× 26 212
Gul Ahsan United Kingdom 4 66 1.0× 56 1.5× 55 1.6× 21 0.6× 10 0.4× 5 129
Jenna Bergerson United States 8 21 0.3× 13 0.4× 40 1.1× 23 0.7× 28 1.2× 17 162
Tom Sidwell Australia 7 32 0.5× 47 1.3× 18 0.5× 17 0.5× 8 0.3× 9 223
Aaron Seese United States 6 27 0.4× 28 0.8× 25 0.7× 22 0.6× 33 1.4× 9 114

Countries citing papers authored by Tilman Schöning

Since Specialization
Citations

This map shows the geographic impact of Tilman Schöning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilman Schöning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilman Schöning more than expected).

Fields of papers citing papers by Tilman Schöning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tilman Schöning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilman Schöning. The network helps show where Tilman Schöning may publish in the future.

Co-authorship network of co-authors of Tilman Schöning

This figure shows the co-authorship network connecting the top 25 collaborators of Tilman Schöning. A scholar is included among the top collaborators of Tilman Schöning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tilman Schöning. Tilman Schöning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Majenka, Pawel, Carmen Loquai, Tilman Schöning, Alexander Enk, & Jessica C. Hassel. (2023). Acute low back pain as infusion-related reaction to monoclonal antibodies. Frontiers in Oncology. 13. 1161818–1161818. 1 indexed citations
2.
Langebrake, Claudia, et al.. (2022). Medication errors in cancer therapy: Reports from German hospital pharmacists between 2008 and 2019. Journal of Oncology Pharmacy Practice. 29(6). 1443–1453. 1 indexed citations
3.
Radujkovic, Aleksandar, Maria‐Luisa Schubert, Paul Schnitzler, et al.. (2020). Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data. Annals of Hematology. 100(8). 2087–2093. 32 indexed citations
4.
5.
Lisenko, Katharina, Fabienne McClanahan, Tilman Schöning, et al.. (2016). Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma. BMC Cancer. 16(1). 267–267. 8 indexed citations
6.
Lisenko, Katharina, Fabienne McClanahan, Tilman Schöning, et al.. (2015). Minimal Renal Toxicity after Rituximab DHAP with a Modified Cisplatin Application Scheme in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma. Blood. 126(23). 1506–1506.
7.
8.
Radujkovic, Aleksandar, Sascha Dietrich, Tilmann Bochtler, et al.. (2014). Azacitidine and low‐dose cytarabine in palliative patients with acute myeloid leukemia and high bone marrow blast counts – a retrospective single‐center experience. European Journal Of Haematology. 93(2). 112–117. 8 indexed citations
9.
Altmann, Annette, Annette Markert, Vasileios Askoxylakis, et al.. (2012). Antitumor Effects of Proteasome Inhibition in Anaplastic Thyroid Carcinoma. Journal of Nuclear Medicine. 53(11). 1764–1771. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miriam Grazia Ferrara Breakdown of academic impact, for papers by Stefano Di Cecca Breakdown of academic impact, for papers by Dai Keino Breakdown of academic impact, for papers by Alessandro Farris Breakdown of academic impact, for papers by April Shamy Breakdown of academic impact, for papers by Vasiliki Chasapi Breakdown of academic impact, for papers by Gul Ahsan Breakdown of academic impact, for papers by Jenna Bergerson Breakdown of academic impact, for papers by Tom Sidwell Breakdown of academic impact, for papers by Aaron Seese
Rankless by CCL
2026